GlassScriptPrepare for your visit
Shirley Ulep
Toms River, NJ · NPI 1740245133
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,391.74
in general payments reported to CMS, 2019-2025 · $474 in 2025
The $474 reported for 2025 was more than what 78% of providers received nationally.
Who reported paying
General payments only, top 6 by amount.
- Genentech USA, INC. $167.61
- Kowa Pharmaceuticals America, INC. $140.11
- Glaxosmithkline, LLC. $138.36
- Merck Sharp & Dohme LLC $138.18
- Ars Pharmaceuticals Operations, INC. $136.01
- Aytu Biopharma, INC. $133.22
Drugs and devices associated with these payments
Neffy Zoryve Xolair Bexsero Beyfortus Tzield Vaxneuvance Gardasil 9 Menquadfi Vaxelis Rotateq Koselugo
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Shirley Ulep listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1387606/shirley-ulep